Trials / Conditions / Relapsed or Refractory Hematological Malignancies
Relapsed or Refractory Hematological Malignancies
3 registered clinical trials studyying Relapsed or Refractory Hematological Malignancies — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Early Clinical Study of JY306 Universal NK Cell Injection in the Treatment of Adult Relapsed or Refractory CD7 NCT06837389 | The First Affiliated Hospital with Nanjing Medical University | EARLY_Phase 1 |
| Unknown | A Clinical Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Injection (CNCT19) in the Treatment of Cluster NCT04011293 | Shandong University | EARLY_Phase 1 |
| Completed | Study of ENMD-2076 in Patients With Relapsed or Refractory Hematological Malignancies NCT00904787 | CASI Pharmaceuticals, Inc. | Phase 1 |